Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCMFlag_hTP53, P72R, V157F (#RDB07475)

Expression vector, mammalian, of human TP53, derived from Lu-139 cell (RCB0469), Gateway(R) expression clone

Alternative name Lu-139
Clone info. Expression vector, mammalian, of human TP53, derived from Lu-139 cell (RCB0469), Gateway(R) expression clone. Expression was confirmed by Western blotting with anti-FLAG and anti-p53 antibodies.
Vector backbone pCMV_S-FLAGc (RDB07396) (Plasmid)
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Gene/insert name Human tumor protein p53 cDNA
Depositor|Developer DNA Bank, | Kishikawa, Shotaro |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The RECIPIENT agrees to use the MATERIAL only for academic research in the non-profit organization and to describe RIKEN BRC as the source of the MATERIAL in any publication.
Remarks An additional fee for license fee of Gateway(R) Expression Vector is required.
Gateway® Expression clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。発表に際し、理研BRCから入手したことを明記すること。
備考 Gateway(R)発現ベクター。ライセンス料相当額を負担して頂きます。
Gateway®テクノロジーを用いた発現クローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07475 pCMFlag_hTP53, P72R, V157F DNA solution JPY 9,460 (not-for-profit academic purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge plus licensing fee equivalent for Gateway® expression clone

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCMFlag_hTP53, P72R, V157F was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07475).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07475_A7Khp1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV-Forward
Sequence file: RDB07475_A7Kha.seq check
>07475_07475_A7Kh_CMV-Forward_G04_19_ABI24.ab1
    1 TTTTCACTCC GCCCATTGAC GCAATGGGCG GTAGGCGTGT ACGGTGGGAG GTCTATATAA
   61 GCAGAGCTCT CTGGCTAACT AGAGAACCCA CTGCTTACTG GCTTATCGAA ATTAATACGA
  121 CTCACTATAG GGAGACCCAA GCTGAATTCA CCATGGACTA CAAGGACGAT GACGATAAGG
  181 CGGCCATCAC AAGTTTGTAC AAAAAAGCAG GCTCGGAGGA GCCGCAGTCA GATCCTAGCG
  241 TCGAGCCCCC TCTGAGTCAG GAAACATTTT CAGACCTATG GAAACTACTT CCTGAAAACA
  301 ACGTTCTGTC CCCCTTGCCG TCCCAAGCAA TGGATGATTT GATGCTGTCC CCGGACGATA
  361 TTGAACAATG GTTCACTGAA GACCCAGGTC CAGATGAAGC TCCCAGAATG CCAGAGGCTG
  421 CTCCCCGCGT GGCCCCTGCA CCAGCAGCTC CTACACCGGC GGCCCCTGCA CCAGCCCCCT
  481 CCTGGCCCCT GTCATCTTCT GTCCCTTCCC AGAAAACCTA CCAGGGCAGC TACGGTTTCC
  541 GTCTGGGCTT CTTGCATTCT GGGACAGCCA AGTCTGTGAC TTGCACGTAC TCCCCTGCCC
  601 TCAACAAGAT GTTTTGCCAA CTGGCCAAGA CCTGCCCTGT GCAGCTGTGG GTTGATTCCA
  661 CACCCCCGCC CGGCACCCGC TTCCGCGCCA TGGCCATCTA CAAGCAGTCA CAGCACATGA
  721 CGGAGGTTGT GAGGCGCTGC CCCCACCATG AGCGCTGCTC AGATAGCGAT GGTCTGGCCC
  781 CTCCTCAGCA TCTTATCCGA GTGGAAGGAA ATTTGCGTGT GGAGTATTTG GATGACAGAA
  841 ACACTTTTCG ACATAGTGTG GTGGTGCCCT ATGAGCCGCC TGAGGTTGGC TCTGACTGTA
  901 CCACCATCCA CTACAACTAC ATGTGTAACA GTTCCTGCAT GGGCGGCATG AACCGGGAGG
  961 CCCATCCTCA CCATCATCAC ACTGGTAAGA CTCCAGTGGT AATCTACTGG GACGGGAACA
 1021 GCTTTGAGGT GCGTGTTGTG CCTGTCCTGG AGAGACCGGG CGCACAGAGA GGAGATCTCC
1081 GGCAGAAGGG GAGCTTCACT CACGAGCCTG CCTCTCCAGG GAGAGCCACC TTAAAAG
//
Primer: BGH_rev2
Sequence file: RDB07475_A7Khb.seq check
>07475_07475_A7Kh_BGH_rev2_H04_22_ABI24.ab1
    1 CGATCAAGGA TCAGGTAGGC ACGGGGGAGG GGCAAACACA GATGGCTGGC AACTAGAAGG
   61 CACAGTCGAG GCTGATCAGC GAGCTCTAGC ATTTAGGTGA CACTATAGAA TAGGGCCCTC
  121 TAGATGCATG CTCGAGCGGC CATCACCACT TTGTACAAGA AAGCTGGGTT CAGTCTGAGT
  181 CAGGCCCTTC TGTCTTGAAC ATGAGTTTTT TATGGCGGGA GGTAGACTGA CCCTTTTTGG
  241 ACTTCAGGTG GCTGGAGTGA GCCCTGCTCC CCCCTGGCTC CTTCCCAGCC TGGGCATCCT
  301 TGAGTTCCAA GGCCTCATTC AGCTCTCGGA ACATCTCGAA GCGCTCACGC CCACGGATCT
  361 GAAGGGTGAA ATATTCTCCA TCCAGTGGTT TCTTCTTTGG CTGGGGAGAG GAGCTGGTGT
  421 TGTTGGGCAG TGCTCGCTTA GTGCTCCCTG GGGGCAGCTC GTGGTGAGGC TCCCCTTTCT
  481 TGCGGAGATT CTCTTCCTCT GTGCGCCGGT CTCTCCCAGG ACAGGCACAA ACACGCACCT
  541 CAAAGCTGTT CCGTCCCAGT AGATTACCAC TGGAGTCTTC CAGTGTGATG ATGGTGAGGA
  601 TGGGCCTCCG GTTCATGCCG CCCATGCAGG AACTGTTACA CATGTAGTTG TAGTGGATGG
  661 TGGTACAGTC AGAGCCAACC TCAGGCGGCT CATAGGGCAC CACCACACTA TGTCGAAAAG
  721 TGTTTCTGTC ATCCAAATAC TCCACACGCA AATTTCCTTC CACTCGGATA AGATGCTGAG
  781 GAGGGGCCAG ACCATCGCTA TCTGAGCAGC GCTCATGGTG GGGGCAGCGC CTCACAACCT
  841 CCGTCATGTG CTGTGACTGC TTGTAGATGG CCATGGCGCG GAAGCGGGTG CCGGGCGGGG
  901 GGTGTGGAAT CAACCCACAG CTGCACAGGG CAGGTCTTGG CCAGTTGGCA AAACATCTTG
  961 TTGAGGGCAG GGGAGTACGT GCAAGTCACA GACTTTGGCT GTCCCAGAAA TGCAAGAAGC
 1021 CCAGACGGAA ACCCGTAGCT GCCCTGGTAG TTTTCTGGTA GGGACAGAGA TGGACAGGGG
 1081 CAGAGGGGGC TGTTGCAGGG ACCGTCGATG TAAGAGCTGG CTTGTTGCAG GGGTCCCACG
1141 CCCGAG
//
Primer: SV40pro_F_V2
Sequence file: RDB07475_A7Khc.seq check
>07475_07475_A7Kh_SV40pro_F_V2_A05_02_ABI24.ab1
    1 CTCCACCTTT TTTGGGAGGC CTAGGCTTTT GCAAAAGCTC CCGGGAGCTT GGATATCCAT
   61 TTTCGGATCT GATCAAGAGA CAGGATGAGG ATCGTTTCGC ATGATTGAAC AAGATGGATT
  121 GCACGCAGGT TCTCCGGCCG CTTGGGTGGA GAGGCTATTC GGCTATGACT GGGCACAACA
  181 GACAATCGGC TGCTCTGATG CCGCCGTGTT CCGGCTGTCA GCGCAGGGGC GCCCGGTTCT
  241 TTTTGTCAAG ACCGACCTGT CCGGTGCCCT GAATGAACTG CAGGACGAGG CAGCGCGGCT
  301 ATCGTGGCTG GCCACGACGG GCGTTCCTTG CGCAGCTGTG CTCGACGTTG TCACTGAAGC
  361 GGGAAGGGAC TGGCTGCTAT TGGGCGAAGT GCCGGGGCAG GATCTCCTGT CATCTCACCT
  421 TGCTCCTGCC GAGAAAGTAT CCATCATGGC TGATGCAATG CGGCGGCTGC ATACGCTTGA
  481 TCCGGCTACC TGCCCATTCG ACCACCAAGC GAAACATCGC ATCGAGCGAG CACGTACTCG
  541 GATGGAAGCC GGTCTTGTCG ATCAGGATGA TCTGGACGAA GAGCATCAGG GGCTCGCGCC
  601 AGCCGAACTG TTCGCCAGGC TCAAGGCGCG CATGCCCGAC GGCGAGGATC TCGTCGTGAC
  661 CCATGGCGAT GCCTGCTTGC CGAATATCAT GGTGGAAAAT GGCCGCTTTT CTGGATTCAT
  721 CGACTGTGGC CGGCTGGGTG TGGCGGACCG CTATCAGGAC ATAGCGTTGG CTACCCGTGA
  781 TATTGCTGAA GAGCTTGGCG GCGAATGGGC TGACCGCTTC CTCGTGCTTT ACGGTATCGC
  841 CGCTCCCGAT TCGCAGCGCA TCGCCTTCTA TCGCCTTCTT GACGAGTTCT TCTGAGCGGG
  901 ACTCTGGGGT TCGAAATGAC CGACCAAGCG ACGCCCAACC TGCCATCACG AGATTTCGAT
  961 TCCACCGCCG CCTTCTATGA AAGGTTGGGC TTCGGAATCG TTTTTCCGGG ACGCCCGGGC
 1021 TGGATGATCC TTCCAGCGGC GGGGATCTCA TGCTGGAGTT CTTTCGCCCA CCCCCACTTT
 1081 GTTTATTGCA GCCTTATATT GTACAATAAG GCAATAGCAT TCCACCAATT TTTCCACCAA
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles